A study of changes in insulin requirements related to the menstrual cycle in Japanese women with type 1 diabetes using the advanced hybrid closed‐loop system
During AHCL therapy, insulin requirements increased and glycemic control modestly worsened in the late‐luteal phase, and no clear associations between phase‐related metabolic changes and menstrual symptom scores or PMDD screening status were detected in this small cohort.